The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients
Abstract
The prevalence of left ventricular hypertrophy (LVH) rises with severity of hypertension (HT), age, and obesity. Its prevalence ranges from 20% in mildly hypertensive patients to almost 100% in those with severe or complicated HT. However, the diagnosis of LVH is not straightforward, and the definitions and criteria used in clinical studies lack consistency. While many factors play a role in the onset and progression of LVH, blood pressure (BP) is recognized as a central factor. Twenty-four-hour BP measurements are more closely related to LVH than conventional BP readings taken in the clinician's office. Increased renin-angiotensin system (RAS) activity also plays an important role in the development of LVH, and various studies show a correlation between plasma renin activity and left ventricular mass (LVM). LVH is a recognized marker of HT-related target organ damage, and a strong and independent risk factor for adverse cardiovascular (CV) outcomes. CV risk increases with increasing LVM, and decreases with regression of LVH in response to antihypertensive treatment. Therefore the detection, prevention, and reversal of LVH are important goals in HT management. Most antihypertensive drugs can attenuate BP and LVH. However, each drug class may induce LVH regression to a different extent and these extents seldom correlate with the degree of BP reduction achieved. Data from the few large comparative studies in this area suggest that certain classes of antihypertensive drugs and/or their combinations are more effective than others. In particular, calcium channel blockers and drugs that target the RAS, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), appear to have a specific effect on LVH, independent of BP reduction. Guidelines, therefore, have recommended these drug classes for the treatment of hypertensive patients with LVH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-5-345 · Cited by 2,366
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,980
The CAFE Investigators, CAFE Steering Committee and Writing Committee, Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A., Collier, D., Hughes, A. D., Thurston, H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.595496 · Cited by 1,645
Parati, G., Pomidossi, G., Albini, F., Malaspina, D., & Mancia, G. (1987) · Journal of Hypertension · doi:10.1097/00004872-198702000-00013 · Cited by 952
Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
Devereux, R. B. (2004) · JAMA · doi:10.1001/jama.292.19.2350 · Cited by 881
A point-score system for the ECG diagnosis of left ventricular hypertrophy
Romhilt, D. W., & Estes, E. H. (1968) · American Heart Journal · doi:10.1016/0002-8703(68)90035-5 · Cited by 856
LEVY, D., ANDERSON, K. M., SAVAGE, D. D., KANNEL, W. B., CHRISTIANSEN, J. C., & CASTELLI, W. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-7 · Cited by 812
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
Klingbeil, A. U., Schneider, M., Martus, P., Messerli, F. H., & Schmieder, R. E. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00158-x · Cited by 761
Self-citationKANNEL, W. B., GORDON, T., & OFFUTT, D. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-1-89 · Cited by 753
Prognostic implications of left ventricular hypertrophy
Vakili, B. A., Okin, P. M., & Devereux, R. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113218 · Cited by 712
Renin-angiotensin system and cardiovascular risk
Schmieder, R. E., Hilgers, K. F., Schlaich, M. P., & Schmidt, B. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60242-6 · Cited by 663
Self-citationPrognostic value of 24-hour blood pressure variability
Frattola, A., Parati, G., Cuspidi, C., Albini, F., & Mancia, G. (1993) · Journal of Hypertension · doi:10.1097/00004872-199310000-00019 · Cited by 659
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003) · Circulation · doi:10.1161/01.cir.0000091405.00772.6e · Cited by 623
Mancia, G., Zanchetti, A., Agebiti-Rosei, E., Benemio, G., De Cesaris, R., Fogari, R., Pessino, A., Porcellati, C., Salvetti, A., & Trimarco, B. (1997) · Circulation · doi:10.1161/01.cir.95.6.1464 · Cited by 596
Casale, P. N., Devereux, R. B., Kligfield, P., Eisenberg, R. R., Miller, D. H., Chaudhary, B. S., & Phillips, M. C. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80115-7 · Cited by 581
Levy, D., Labib, S. B., Anderson, K. M., Christiansen, J. C., Kannel, W. B., & Castelli, W. P. (1990) · Circulation · doi:10.1161/01.cir.81.3.815 · Cited by 531
Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension
Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., & Perticone, F. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.580 · Cited by 530
Clinical Relevance of Nighttime Blood Pressure and of Daytime Blood Pressure Variability
Palatini, P. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.9.1855 · Cited by 424
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Bartoccini, C., Santucci, A., Santucci, C., Reboldi, G., & Porcellati, C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00424-o · Cited by 408
Paradis, P., Dali-Youcef, N., Paradis, F. W., Thibault, G., & Nemer, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.931 · Cited by 382
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study
Verdecchia, P., Carini, G., Circo, A., Dovellini, E., Giovannini, E., Lombardo, M., Solinas, P., Gorini, M., & Maggioni, A. P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01663-1 · Cited by 381
Muiesan, M. L., Salvetti, M., Monteduro, C., Bonzi, B., Paini, A., Viola, S., Poisa, P., Rizzoni, D., Castellano, M., & Agabiti-Rosei, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000121223.44837.de · Cited by 330
Solomon, S. D., Janardhanan, R., Verma, A., Bourgoun, M., Daley, W. L., Purkayastha, D., Lacourcière, Y., Hippler, S. E., Fields, H., Naqvi, T. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60980-5 · Cited by 329
Pewsner, D., Jüni, P., Egger, M., Battaglia, M., Sundström, J., & Bachmann, L. M. (2007) · BMJ · doi:10.1136/bmj.39276.636354.ae · Cited by 328
Drazner, M. H., Dries, D. L., Peshock, R. M., Cooper, R. S., Klassen, C., Kazi, F., Willett, D., & Victor, R. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000169972.96201.8e · Cited by 320
Verdecchia, P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01018-5 · Cited by 310
Verdecchia, P., Porcellati, C., Reboldi, G., Gattobigio, R., Borgioni, C., Pearson, T. A., & Ambrosio, G. (2001) · Circulation · doi:10.1161/hc4201.097944 · Cited by 292
Surrogate Markers for Cardiovascular Disease: Functional Markers
Cohn, J. N., Quyyumi, A. A., Hollenberg, N. K., & Jamerson, K. A. (2004) · Circulation · doi:10.1161/01.cir.0000133442.99186.39 · Cited by 284
Blood Pressure Variability and Organ Damage in a General Population: Results from the PAMELA Study
Sega, R., Corrao, G., Bombelli, M., Beltrame, L., Facchetti, R., Grassi, G., Ferrario, M., & Mancia, G. (2002) · Hypertension · doi:10.1161/hy0202.104376 · Cited by 276
Dietary salt intake. A determinant of cardiac involvement in essential hypertension.
Schmieder, R. E., Messerli, F. H., Garavaglia, G. E., & Nunez, B. D. (1988) · Circulation · doi:10.1161/01.cir.78.4.951 · Cited by 265
Self-citationOkin, P. M., Devereux, R. B., Jern, S., Kjeldsen, S. E., Julius, S., Nieminen, M. S., Snapinn, S., Harris, K. E., Aurup, P., Edelman, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083724.28630.c3 · Cited by 257
DESIMONE, G., KIZER, J., CHINALI, M., ROMAN, M., BELLA, J., BEST, L., LEE, E., & DEVEREUX, R. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.032 · Cited by 233
Devereux, R. B., Palmieri, V., Sharpe, N., De Quattro, V., Bella, J. N., de Simone, G., Walker, J. F., Hahn, R. T., & Dahlöf, B. (2001) · Circulation · doi:10.1161/hc3601.095927 · Cited by 209
Left ventricular hypertrophy in hypertension: its arrhythmogenic potential
Kahan, T., & Bergfeldt, L. (2005) · Heart · doi:10.1136/hrt.2004.042473 · Cited by 208
Parati, G., Omboni, S., Rizzoni, D., Agabiti-Rosei, E., & Manciaa, G. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00016 · Cited by 198
Roman, M. J., Pickering, T. G., Schwartz, J. E., Pini, R., & Devereux, R. B. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00225-2 · Cited by 195
Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
Agrawal, B., Berger, A., Wolf, K., & Luft, F. C. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00011 · Cited by 191
Gosse, P., Sheridan, D. J., Zannad, F., Dubourg, O., Guéret, P., Karpov, Y., de Leeuw, P. W., Palma-Gamiz, J.-L., Pessina, A., Motz, W., et al. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018100-00015 · Cited by 186
Wachtell, K., Olsen, M. H., Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Nieminen, M. S., Okin, P. M., Papademetriou, V., Mogensen, C. E., Borch-Johnsen, K., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200203000-00015 · Cited by 171
Schmieder, R. E., Langenfeld, M. R. W., Friedrich, A., Schobel, H. P., Gatzka, C. D., & Weihprecht, H. (1996) · Circulation · doi:10.1161/01.cir.94.6.1304 · Cited by 147
Self-citationMancia, G., Carugo, S., Grassi, G. M., Lanzarotti, A., Schiavina, R., Cesana, G., & Sega, R. (2002) · Hypertension · doi:10.1161/hy0302.104669 · Cited by 136
Dahlöf, B., Gosse, P., Guéret, P., Dubourg, O., SIMONE, G. D., Schmieder, R. E., IuA, K., Puig, J. G., Matos, L., de Leeuw, P. W., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000187253.35245.dc · Cited by 105
Self-citationVaudo, G., Schillaci, G., Evangelista, F., Pasqualini, L., Verdecchia, P., & Mannarino, E. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00229-0 · Cited by 89
The role of non-haemodynamic factors of the genesis of LVH
Schmieder, R. E. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi190 · Cited by 76
Self-citationAgabiti‐Rosei, E., Muiesan, M. L., & Salvetti, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121336 · Cited by 76
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension
Leoncini, G., Sacchi, G., Ravera, M., Viazzi, F. C., Ratto, E., Vettoretti, S., Parodi, D., Bezante, G. P., Sette, M. D., Deferrari, G., et al. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001408 · Cited by 74
Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects
Verdecchia, P., Angeli, F., Gattobigio, R., Sardone, M., Pede, S., & Reboldi, G. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.018 · Cited by 71
Malmqvist, K. K., Öhman, K. P., Lind, L., Nyström, F. H., & Kahan, T. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01053.x · Cited by 70
Vlahakos, D., Hahalis, G. N., Vassilakos, P. J., Marathias, K. P., & Geroulanos, S. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8111764 · Cited by 60
Impact of the time rate of blood pressure variation on left ventricular mass
Zakopoulos, N., Tsivgoulis, G. K., Barlas, G., Spengos, K. M., Manios, E. D., Ikonomidis, I., Toumanidis, S., Dolianitis, K., Vemmos, K. N., Vassilopoulos, D., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244957.47114.88 · Cited by 59
The assessment of left ventricular hypertrophy in hypertension
Alfakih, K., Reid, S., Hall, A. S., & Sivananthan, M. U. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000234097.47379.fd · Cited by 57
Prevalence of left ventricular hypertrophy in a hypertensive population
Tingleff, J., Munch, M., Jakobsen, T. J., Torp-Perdersen, C., Olsen, M. E., Jensen, K., Jørgensen, T., & Kirchoff, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014672 · Cited by 56
Dell’Omo, G., Giorgi, D., Bello, V. D., Mariani, M., & Pedrinelli, R. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01155.x · Cited by 50
Direct renin inhibitors: the dawn of a new era, or just a variation on a theme?
Segall, L., Covic, A. C., & Goldsmith, D. J. A. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm363 · Cited by 42
Norman, J. E., & Levy, D. A. (1996) · Journal of Electrocardiology · doi:10.1016/s0022-0736(96)80070-7 · Cited by 39
Tsioufis, C. P., Stefanadis, C., Toutouza, M. G., Kallikazaros, I. E., Toutouzas, K., Tousoulis, D., Pitsavos, C. E., Papademetriou, V., & TOUTOUZAS, P. K. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001379 · Cited by 38
Inadequate suppression of angiotensin II modulates left ventricular structure in humans.
Schlaich, M. P., Schobel, H.-P., Langenfeld, M. R. W., Hilgers, K. F., & Schmieder, R. E. (1998) · PubMed · Cited by 32
Self-citationBoersma, C., Thobari, J. A., Gansevoort, R. T., den Berg, L. T. W. D. J., de Jong, P. E., de Zeeuw, D., Annemans, L., & Postma, M. J. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624060-00001 · Cited by 27
Saitoh, M., MATSUO, K., NOMOTO, S., Kondoh, T., YANAGAWA, T., Katoh, Y., & Hasegawa, K. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.576 · Cited by 26
Parati, G., Vrijens, B., & Vincze, G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2007.27 · Cited by 25
Anis, A. H., Sun, H., Singh, S., Woolcott, J. C., Nosyk, B., & Brisson, M. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624040-00008 · Cited by 19
Antoniucci, D., Seccareccia, F., Menotti, A., et al. (1997) · PubMed · Cited by 18
Prevalence of Left Ventricular Hypertrophy and Cardiac Arrhythmias in Borderline Hypertension
Melina, D., Colivicchi, F., Guerrera, G., Melina, G., Frustaci, A., Caldarulo, M., & Guerrera, C. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.8.570 · Cited by 17
Zakopoulos, N. A., Ikonomidis, I., Vemmos, K. N., Manios, E. G., Spiliopoulou, I., Tsivgoulis, G. K., Spengos, K., PSALTOPOULOU, D., Mavrikakis, M., & Moulopoulos, S. D. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.06.033 · Cited by 16
Left Ventricular Hypertrophy Reversal and Prevention of Diabetes: Two Birds With One Stone?
Schillaci, G., Pirro, M., & Mannarino, E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.099747 · Cited by 12
VALIDD should not invalidate angiotensin-receptor blockers
Ahmed, A., Perry, G. J., & Husain, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60955-6 · Cited by 6
Do we understand why regression of left ventricular hypertrophy is beneficial?
Kaplinsky, E. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.015 · Cited by 3
Cited by
Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.034 · Cited by 501
Cuspidi, C., Sala, C., Negri, F., Mancia, G., Morganti, A., & on behalf of the Italian Society of Hypertension (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2011.104 · Cited by 333
Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · Europace · doi:10.1093/europace/eur002 · Cited by 312
Influence of Physical Activity on Hypertension and Cardiac Structure and Function
Hegde, S. M., & Solomon, S. D. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0588-3 · Cited by 272
Optimal critical mass in the two dimensional Keller–Segel model in R 2
Dolbeault, J., & Perthame, B. (2004) · Comptes Rendus. Mathématique · doi:10.1016/j.crma.2004.08.011 · Cited by 262
Metadata
- Authors
- Ruilope, L. M., & Schmieder, R. E.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-01
- Volume
- 21
- Issue
- 5
- Pages
- 500-508
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W2034336585
- Cited by
- 258
- References
- 70
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.